Adjuvant endocrine therapy for premenopausal breast cancer patients should be individualized
Oncologists should take an individualized approach when making decisions about adjuvant endocrine therapies for premenopausal hormone receptor–positive, HER2-negative early breast cancer, suggests an...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Endocrinology | HER2 | Hormones